Assenagon Asset Management S.A.
Position in KURA — Kura Oncology, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in KURA
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$2,937,195
+$175,337 QoQ
Shares Held
267,748
-21.2% QoQ
Ownership
0.301%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 220 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,940,218,245 across 69 Biotechnology names. KURA ranks #40 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in KURA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,937,195 | 267,748 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $2,761,858 | 339,712 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $11,896,716 | 1,145,016 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $11,195,515 | 1,265,030 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $5,303,085 | 919,079 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $6,065,921 | 919,079 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $7,884,152 | 905,184 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $20,557,311 | 1,052,063 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $35,653,170 | 1,731,577 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $24,611,513 | 1,153,845 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $16,592,291 | 1,153,845 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $10,523,066 | 1,153,845 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $12,207,680 | 1,153,845 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $14,111,524 | 1,153,845 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $14,319,216 | 1,153,845 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $15,797,612 | 1,156,487 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $21,198,406 | 1,156,487 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $27,017,551 | 1,680,196 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $7,305,760 | 521,840 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $15,701,977 | 838,333 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $11,135,547 | 534,079 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $3,341,514 | 118,200 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $3,860,412 | 118,200 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $9,908,976 | 323,400 | Shares | Sole | 2020-10-07 | |
| No filing history on record for this holder in this stock. | ||||||